Health Condition 1: F429- Obsessive-compulsive disorder, unspecified
Conditions
Interventions
Intervention1: Fluvoxamine: As per the PI the effective dosage usually lies between 100 mg and 300 mg per day The dosage should be increased gradually until the effective dosage is achieved with a max
Sponsors
Abbott Healthcare Ltd
Eligibility
Inclusion criteria
Inclusion criteria: Male or female patients aged equal to or more than 18 years who are sexually active Patient with a confirmed diagnosis of OCD as per DSM 5 TR criteria Treatment na ve patients (Patients who have discontinued the medication for 3 months or more will also be considered a treatment na ve Patients willing to provide written informed consent
Exclusion criteria
Exclusion criteria: Currently on treatment for OCD Other severe mental illnesses schizophrenia bipolar disorder substance or alcohol dependence Patients who had contraindications for the use of the study drug Patients receiving concomitant medications that have known or potential drug-drug interactions Patients receiving concomitant medications that are known to cause sexual side effects Pregnant or nursing females Women in the peri or post menopausal age group
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of incidence and severity of sexual side effects using the ASEX questionnaire at baseline 3 months and 6 monthsTimepoint: Evaluation of incidence and severity of sexual side effects using the ASEX questionnaire at baseline 3 months and 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Effectiveness Percentage improvement in Y BOCS questionnaire scores as compared to baseline versus each visit Percentage incidence of drug related adverse effects at each visit Improvement in QoL scores using the RAND 36 Item Short Form Health Survey questionnaire at baseline 3 months and 6 monthsTimepoint: baseline 3 months and 6 months | — |
Countries
India
Contacts
Public ContactDr Mrugesh Vaishnav
Samvedana Happiness Hospital
Outcome results
None listed